PureTech Health (PRTC) Long-Term Investments (2019 - 2025)

PureTech Health (PRTC) has 5 years of Long-Term Investments data on file, last reported at $217.4 million in Q4 2025.

• Long-Term Investments for Q4 2025 came in at $217.4 million, up 13.58% year-over-year; the trailing twelve-month figure through Dec 2025 was $217.4 million (up 13.58% YoY), and the FY2025 annual result was $217.4 million, up 13.58% from the prior year.
• Long-Term Investments grew to $217.4 million in Q4 2025 per PRTC's latest filing, from $191.8 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $317.8 million in Q4 2023 and troughed at $191.4 million in Q4 2024.
• A 4-year average of $234.1 million and a median of $217.4 million in 2025 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2023 and 2024: Long-Term Investments gained 26.18% in 2023, then plunged 39.77% in 2024.
• A 4-year view of Long-Term Investments shows it stood at $251.9 million in 2022, then grew by 26.18% to $317.8 million in 2023, then tumbled by 39.77% to $191.4 million in 2024, then climbed by 13.58% to $217.4 million in 2025.
• Business Quant data shows PRTC's Long-Term Investments at $217.4 million in Q4 2025, $191.8 million in Q2 2025, and $191.4 million in Q4 2024.